StonvexLoading…
StonvexStonvexStonvexCore line items from VEON's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.40B | $4.00B | $3.70B | $3.75B |
Operating Income | $1.44B | $1.11B | $929.00M | $1.16B |
Net Income | $591.00M | $487.00M | $-2.45B | $-9.00M |
EPS (Diluted) | $0.30 | $0.23 | $-1.44 | $-0.09 |
Total Assets | $9.21B | $8.04B | $8.22B | $15.08B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.73B | $1.69B | $1.90B | $3.11B |
Free Cash Flow OCF − CapEx | $620.00M | $523.00M | $629.00M | $299.00M |
Shares Outstanding | Not available | Not available | Not available | Not available |